Vanc Pharmaceuticals, Inc.

Vanc Pharmaceuticals, Inc.

Vanc Pharmaceuticals, Inc.

Overview
Date Founded

2000

Headquarters

800 West Pender Street,Suite 615,Vancouver, BC V6C 2V6

Type of Company

Public

Employees (Worldwide)

2

Industries

Pharmaceuticals

Company Description

Avricore Health, Inc. engages in the manufacture and sale of over-the-counter healthcare products. Its products include Hema-fer, Cortivera and Sennace. The company was founded on May 30, 2000 and is headquartered in Vancouver, Canada.

Executives & Employees

President, Chief Executive Officer & Director

Chief Executive Officer & Executive Director

Chief Financial Officer

Financial Controller

Director, Pharmacy Solutions

Executive Vice President, Branding, Strategic Communications & Public Affairs

Corporate Secretary

Executive Consultant

Regulatory Affairs Associate

Medical Affairs Associate

Board of Directors

Former President, Chief Executive Officer & Director at RepliCel Life Sciences, Inc.

Chief Executive Officer & Executive Director at Vanc Pharmaceuticals, Inc.

Professor at University of British Columbia

Director at Vanc Pharmaceuticals, Inc.

Former Vice President, Commodities at George Weston Limited

Paths to Vanc Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Vanc Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Vanc Pharmaceuticals, Inc. purchases HealthTab, Inc.

Details Hidden

Vanc Pharmaceuticals, Inc. purchases Seavan Health & Beauty Partnership

Details Hidden

Vanc Pharmaceuticals, Inc. purchases ALDA Pharmaceuticals, Inc.

Transaction Advisors
Legal Advisor

Advised onVanc Pharmaceuticals, Inc. issued Common Stock

Auditor

Advised onVanc Pharmaceuticals, Inc. issued Common Stock

Underwriter

Advised onVanc Pharmaceuticals, Inc. issued Common Stock

Key Stats and Financials As of 2017
Market Capitalization
$4.12M
Total Enterprise Value
$5.33M
Earnings Per Share
$-0.15
Revenue
$538K
Net Profit
$-2.74M
EBITDA
$-2.75M
EBITDAMargin
-511.72%
Total Debt
$0
Total Equity
$2.5M
Enterprise Value Sales
9.91x
TEVNet Income
-1.95x
Debt TEV
0x
Five Year Compounded Annual Growth Rate Of Revenue
45.18%
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vanc Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vanc Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vanc Pharmaceuticals, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/vanc-pharmaceuticals-inc-67330
  • https://relationshipscience.com/organization/vanc-pharmaceuticals-inc-67330